Advanced or Metastatic Solid Tumors in Patients With Hepatic Impairment

Explore clinical trials studying Advanced or Metastatic Solid Tumors in Patients With Hepatic Impairment. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies

Refine in advanced search Browse all conditions

Advanced or Metastatic Solid Tumors in Patients With Hepatic Impairment trial results

Completed

A Study in Cancer Patients With Hepatic Impairment to Evaluate the Pharmacokinetics and Safety of NKTR-102 (Etirinotecan Pegol)

NCT01991678

Conditions: Advanced or Metastatic Solid Tumors in Patients With Hepatic Impairment
Locations: USC/LA County Los Angeles, California, United States

UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States

University Hospitals Case-Medical Center Seidman Cancer Center Cleveland, Ohio, United States

View Trial Details